DOI:
10.1055/s-00000131
Synfacts
LinksClose Window
References
Brodney M. * et al. Pfizer, Inc., Cambridge and Groton, USA
Design and Synthesis of Clinical Candidate PF-06751979: A Potent, Brain Penetrant, β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor Lacking Hypopigmentation.
J. Med. Chem. 2018;
61: 4476-4504
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.